Dr. Metcalf leads GSK’s Centre of Innovation to enhance pharmacovigilance, benefit-risk evaluation, and collaboration with patients. The Centre strives to advance insight, communication, and work practices by engaging with partners inside and outside the company. Dr. Metcalf is a member of GSK’s Global Safety Board and Central Safety Department Leadership Team. She participates in patient/industry/academic alliances including Patients as Partners, DIA Patient Engagement, and TransCelerate.

Conny Berlin leads the department Quantitative Safety and Epidemiology at Novartis Pharma AG. Her responsibilities include supervising a team of statisticians and epidemiologists, providing epidemiology support for all clinical programs and promoting a quantitative safety culture which enables evaluation, understanding and communication of safety data and benefit-risk to support decision-making at all stages of the drug life-cycle.